87 results
Page 4 of 5
6-K
EX-1.1
l44eecbxmxo7maucq
7 Mar 14
BioLineRx Closes $24.1 Million Underwritten Public Offering
12:00am
424B5
xjwoiq
4 Mar 14
Prospectus supplement for primary offering
12:00am
424B5
33chh4i clv1nr4
3 Mar 14
Prospectus supplement for primary offering
12:00am
424B3
4qbxt7qn2iovvvhnn8i
8 Aug 13
Prospectus supplement
12:00am
6-K
EX-99
agq9v2ax4sf6 vhx
10 Jul 13
2013 Annual General Meeting of Shareholders
12:00am
6-K
EX-99
vuq8b
5 Jun 13
Extraordinary General Meeting of Shareholders
12:00am
6-K
EX-10.1
fa8owbc whrh4m2
17 May 13
BioLineRx Enters into “At-The-Market” Offering
12:00am
424B3
3sj8ei5
15 Oct 12
Prospectus supplement
12:00am
F-1
7iiw 6rkdhxi
2 Oct 12
Registration statement (foreign)
12:00am
6-K
EX-99
k2ttt1aq6 5vxyf6t4
27 Sep 12
Current report (foreign)
12:00am
S-8
EX-5.1
tn832 ap3w
19 Sep 12
Registration of securities for employees
12:00am
S-8
nx5nd1125874mqym6ho
19 Sep 12
Registration of securities for employees
12:00am
S-8
EX-5.2
cn99t s5u82
19 Sep 12
Registration of securities for employees
12:00am
6-K
EX-99
fyi1tyxj7fhy5
15 Aug 12
BioLineRx Reports Second Quarter 2012 Results
12:00am
6-K
EX-99
itqprzdlm m4
5 Apr 12
2012 Annual General Meeting of Shareholders
12:00am
6-K
EX-1
r9yytl5f
13 Oct 11
Current report (foreign)
12:00am
S-8
EX-5.2
2wh4sybnd030q6ti
22 Aug 11
Registration of securities for employees
12:00am
S-8
443dut38u3b 0s
22 Aug 11
Registration of securities for employees
12:00am
S-8
EX-5.1
ffiwyc24
22 Aug 11
Registration of securities for employees
12:00am